Related Experiment Videos
Agmatine-morphine interaction on nociception in mice
Eduardo Ruiz-Durantez1, Javier Llorente, Isabel Ulibarri
1Department of Pharmacology, Faculty of Medicine, University of the Basque Country, Leioa, Vizcaya, Spain.
Annals of the New York Academy of Sciences
|March 19, 2004
Summary
Agmatine enhances morphine pain relief through spinal pathways, not involving nitric oxide. This study clarifies agmatine
Area of Science:
- Pharmacology
- Neuroscience
Background:
- Morphine is a primary analgesic, but its effectiveness can be limited.
- Agmatine, an endogenous amine, has shown potential to modulate pain perception.
- Nitric oxide (NO) is implicated in various physiological processes, including pain signaling.
Purpose of the Study:
- To investigate the role of nitric oxide in agmatine's ability to enhance morphine-induced analgesia.
- To determine if agmatine's effects on morphine analgesia are mediated by the nitric oxide pathway.
Main Methods:
- Experiments were conducted using mice.
- Analgesia was assessed using the tail flick test (spinal) and the hot plate test (supraspinal).
- Agmatine and L-NAME (a nitric oxide synthesis inhibitor) were administered to evaluate their effects on morphine analgesia.
Main Results:
- Both agmatine and L-NAME individually enhanced morphine-induced analgesia in the tail flick test.
- Neither agmatine nor L-NAME affected morphine-induced analgesia in the hot plate test.
- L-NAME did not inhibit the potentiation of morphine analgesia observed with agmatine administration.
Conclusions:
- Agmatine potentiates morphine-induced analgesia at the spinal level.
- Agmatine's potentiation of morphine analgesia is not dependent on nitric oxide synthesis.
- These findings suggest distinct mechanisms for spinal and supraspinal analgesia modulation by agmatine.